Peer-reviewed article
The challenges of optimising the treatment of children diagnosed with idiopathic short stature.
Christopher J Romero, Robert Rapaport ·
Summary
Written by AI, not yet AICS's view · claude-haiku-4-5-20251001This is a peer-reviewed commentary on the challenges of treating children with idiopathic short stature. It discusses the difficulty in determining whether interventions like growth hormone therapy and aromatase inhibitors are truly effective given the heterogeneity of the diagnosis. The commentary references a meta-analysis by Zhang et al. that attempted to compare the effects of different treatments on height gain.
Key points
- Treatment decisions for idiopathic short stature are complicated by the heterogeneity of the diagnosis
- Multiple interventions exist including growth hormone therapy and aromatase inhibitors
- More research is needed to understand the efficacy of various interventions
- A network meta-analysis has attempted to stratify benefits of several treatments
Limitations
This is a commentary on other research rather than a primary study or evaluation. It does not present original data or evaluate an intervention itself, and does not discuss child well-being outcomes beyond height gain.
Abstract
Physicians who treat children with idiopathic short stature (ISS) are challenged in deciding whether the intervention to improve final height is truly efficacious, given the heterogeneity of the diagnosis of ISS. There are numerous studies and reviews that have attempted to assess and demonstrate the benefit of various interventions, such as growth hormone therapy and aromatase inhibitors. Recently, Zhang et al. published a well-written meta-analysis entitled "Comparative effects of growth hormone, testosterone, and aromatase inhibitors on height gain in children and adolescents with idiopathic short statures: a network meta-analysis," attempting to stratify the benefit of several interventions. Our commentary seeks to highlight the importance of more research needed in this field and the complexities of treating children with ISS.